Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frost, D. B.
Right arrow Articles by Tyrell, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frost, D. B.
Right arrow Articles by Tyrell, J. S.

Annals of Surgical Oncology, Vol 1, Issue 4 290-295, Copyright © 1994 by Society of Surgical Oncology

ARTICLES

Small bowel cancer: a 30-year review

D. B. Frost, P. D. Mercado and J. S. Tyrell
Division of Surgical Oncology, Southern California Permanente Medical Group, Los Angeles Medical Center.

BACKGROUND: Small bowel cancer is a relatively rare tumor with an incidence of 2,700 new cases and 900 deaths per year. The influence of stage on survival has been reported only once previously. Patterns of recurrence are unreported. METHODS: All cases of small bowel cancer treated at our hospital over a 30-year period (1960-1989) were reviewed. RESULTS: The site of most cancers was the duodenum (46%), followed in frequency by the jejunum (33%) and the ileum (21%). Adenocarcinoma was the most common histology (63%), followed in frequency by lymphoma (15%), leiomyosarcoma (13%), carcinoid tumors (6%), and miscellaneous (3%). Analysis of stage distribution by site showed a decrease in stages I and II with more distal locations. Associated cancers occurred in 11%, but none were seen in the group with carcinoid tumors. Actuarial 10-year survival rates were 24% for those with adenocarcinoma (all stages) 75% for stage I, 25% for those with stage II, and 0% for stage III. A subgroup of 10 patients who underwent a pancreaticoduodenectomy (one stage I, seven stage II, two stage III) had a 30% 10-year survival rate. Those patients with lymphoma had a 12% 10-year survival rate, and those with leiomyosarcoma had a 20% 10-year survival rate. A 100% 10-year survival rate was observed in those with carcinoid tumors. Peritoneal carcinomatosis was the most common failure pattern (33%), followed in frequency by local recurrence in 23% and abdominal wall recurrence in 15%. CONCLUSIONS: A correlation exists between the pathologic stage and the survival rate for adenocarcinoma. The most common recurrence pattern for adenocarcinoma was carcinomatosis, followed in frequency by abdominal wall recurrence. Leiomyosarcoma preferentially metastasizes to the liver.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
S. Agrawal, E. C. McCarron, J. F. Gibbs, H. R. Nava, G. E. Wilding, and A. Rajput
Surgical Management and Outcome in Primary Adenocarcinoma of the Small Bowel
Ann. Surg. Oncol., August 1, 2007; 14(8): 2263 - 2269.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J.-G. Park, D.-W. Kim, C. W. Hong, B.-H. Nam, Y.-K. Shin, S.-H. Hong, I.-J. Kim, S.-B. Lim, M. Aronson, M. L. Bisgaard, et al.
Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: international society for gastrointestinal hereditary tumours collaborative study.
Clin. Cancer Res., June 1, 2006; 12(11): 3389 - 3393.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
M. S. Talamonti, L. H. Goetz, S. Rao, and R. J. Joehl
Primary Cancers of the Small Bowel: Analysis of Prognostic Factors and Results of Surgical Management
Arch Surg, May 1, 2002; 137(5): 564 - 571.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Society of Surgical Oncology.